Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (0) | Back to Search
HANDLING OF THALIDOMIDE PREPARATION AND ITS DERIVATIVES IN JAPAN AND OUR HOSPITAL'S EFFORTS
- At: 2019 FIP Congress in AbuDhabi (United Arab Emirates)
- Type: Poster
- By: SATO, Mikako (National Hospital Organization Disaster Medical Center, Japan)
- Co-author(s): Mikako Sato: pharmacy, National Hospital Organization Disaster Medical Center, Japan
Multiple myeloma is still incurable disease, however, novel agents have improved the prognosis. Among of them, Immunomodulatory drugs, ImiDs (i.e., Thalidomide, lenalidomide, and pomalidomide) are fundamental drugs for several treatment regimens. ImiDs are thalidomide formulations or thalidomide derivative formulations and are known to The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.
Last update 4 October 2019